Cargando…
Inhaled nitric oxide testing in predicting prognosis in pulmonary hypertension due to left‐sided heart diseases
AIMS: The pathophysiology of pulmonary hypertension (PH) due to left‐sided heart disease (Group 2 PH) is distinct from that of other groups of PH, yet there are still no approved therapies that selectively target pulmonary circulation. The increase in pulmonary capillary pressure due to left‐sided h...
Autores principales: | Satoh, Taijyu, Yaoita, Nobuhiro, Nochioka, Kotaro, Tatebe, Shunsuke, Hayashi, Hideka, Yamamoto, Saori, Sato, Haruka, Takahama, Hiroyuki, Suzuki, Hideaki, Terui, Yosuke, Yamada, Kaito, Yamada, Yusuke, Inoue, Takumi, Aoki, Tatsuo, Satoh, Kimio, Sugimura, Koichiro, Miyata, Satoshi, Yasuda, Satoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682891/ https://www.ncbi.nlm.nih.gov/pubmed/37775984 http://dx.doi.org/10.1002/ehf2.14515 |
Ejemplares similares
-
Beneficial effects of riociguat on hemodynamic responses to exercise in CTEPH patients after balloon pulmonary angioplasty – A randomized controlled study
por: Aoki, Tatsuo, et al.
Publicado: (2020) -
Sex differences in hemodynamic responses and long-term survival to optimal medical therapy in patients with pulmonary arterial hypertension
por: Kozu, Katsuya, et al.
Publicado: (2018) -
Identification of the Novel Variants in Patients With Chronic Thromboembolic Pulmonary Hypertension
por: Yaoita, Nobuhiro, et al.
Publicado: (2020) -
Identification of Adipsin as a Novel Prognostic Biomarker in Patients With Coronary Artery Disease
por: Ohtsuki, Tomohiro, et al.
Publicado: (2019) -
Clinical Diversity in Patients with Anderson-fabry Disease with the R301Q Mutation
por: Yamamoto, Saori, et al.
Publicado: (2018)